By Business/Source
Currency:USD
2025/Q3
Stock NameRevenueRatio
Anti-Viral/ Infection & Respiratory420K55.26%
Central Nervous System (CNS) Cerebral & Cardio Vascular250K32.89%
Digestive Diseases70K9.21%
Other20K2.63%
By Country/Region
Currency:USD
2024/FY
Stock NameRevenueRatio
People's Republic of China (PRC)4.53M100.00%